HIV rapid testing in drug treatment: Comparison across treatment modalities

Journal of Substance Abuse Treatment

Volumn 44, Issue 4, 2013, Pages 369-374

  Schwartz, Robert P ^a   Stitzer, Maxine L ^b   Feaster, Daniel J ^c   Korthuis, P Todd ^d   Alvanzo, Anika A H ^b   Winhusen, Theresa M ^e   Donnard, Lillian ^f   Snead, Ned ^g   Metsch, Lisa R ^c  

^a FRIENDS RESEARCH INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^f Glenwood Life Counseling Center   (United States)

^g Chesterfield Community Services Board   (United States)

Author keywords

Drug treatment programs; HIV rapid testing; HIV risk behavior

Indexed keywords

ALCOHOL; AMPHETAMINE; COCAINE; METHADONE; OPIATE;

ADULT; ANUS INTERCOURSE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ABUSE; DRUG DEPENDENCE TREATMENT; DRUG USE; EDUCATION; FEEDBACK SYSTEM; FEMALE; FOLLOW UP; GENDER; HIGH RISK BEHAVIOR; HIV RAPID TEST; HUMAN; INCIDENCE; INCOME; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MULTICENTER STUDY; OPIATE ADDICTION; OUTPATIENT; PATIENT COUNSELING; PATIENT REFERRAL; PRIORITY JOURNAL; RACE; RANDOMIZED CONTROLLED TRIAL; RESIDENTIAL CARE; RISK REDUCTION; SECONDARY ANALYSIS; SEXUAL INTERCOURSE; TREATMENT DURATION; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGE FACTORS; AIDS SERODIAGNOSIS; EDUCATIONAL STATUS; FEEDBACK, PSYCHOLOGICAL; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INCOME; MALE; NEEDLE SHARING; PATIENT ACCEPTANCE OF HEALTH CARE; RISK-TAKING; SEXUAL BEHAVIOR; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS; UNSAFE SEX;

EID: 84873749866     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2012.08.219     Document Type: Article

References (26)

1. Abraham A.J., OBrien L.A., Knudsen H.K., Bride B.E., Smith G.R., Roman P.M. Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs. Journal of Substance Abuse Treatment 2012, [Epub ahead of print].
2. Bini E.J., Kritz S., Brown L.S., Robinson J., Alderson D., Rotrosen J. Barriers to providing health services for HIV/AIDS, hepatitis C virus infection and sexually transmitted infections in substance abuse treatment programs in the United States. Journal of Addictive Diseases 2011, 30:98-109.
3. Branson B.M., Handsfield H.H., Lampe M.A., Janssen R.S., Taylor A.W., Lyss S.B., Clark J.E., Centers for Disease Control Prevention Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. [Practice Guideline]. MMWR Recommendations and Reports 2006, 55:1-17. [quiz CE11-14].
4. Brown L.S., Kritz S., Goldsmith R.J., Bini E.J., Robinson J., Alderson D., Rotrosen J. Health services for HIV/AIDS, HCV, and sexually transmitted infections in substance abuse treatment programs. Public Health Reports 2007, 122:441-451.
5. Brown L.S., Kritz S.A., Goldsmith R.J., Bini E.J., Rotrosen J., Baker S., Robinson J., McAuliffe P. Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network. Journal of Substance Abuse Treatment 2006, 30:315-321.
6. Des Jarlais D.C., Paone D., Milliken J., Turner C.F., Miller H., Gribble J., Shi Q., Hagan H., Friedman S.R. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: A quasi-randomised trial. The Lancet 1999, 353:1657-1661.
7. Haynes L.F., Korte J.E., Holmes B.E., Gooden L., Matheson T., Feaster D.J., Leff J.A., Wilson L., Metsch L.R., Schackman B.R. HIV rapid testing in substance abuse treatment: Implementation following a clinical trial. Evaluation and Program Planning 2011, 34:399-406.
8. Kaiser Family Foundation (2012) HIV/AIDS Policy. Fact Sheet, State Medicaid Coverage of Routine HIV Screening, The Henry Kaiser Family Foundation, March 2012. Accessed on August 6, 2012. http://www.kff.org/hivaids/upload/8286.pdfwww.kff.org.
9. Knudsen H.K., Oser C.B. Availability of HIV-related health services in adolescent substance abuse treatment programs. AIDS Care 2009, 21:1238-1246.
10. Lott D.C., Strain E.C., Brooner R.K., Bigelow G.E., Johnson R.E. HIV risk behaviors during pharmacologic treatment for opioid dependence: A comparison of levomethadyl acetate [corrected] buprenorphine, and methadone. Journal of Substance Abuse Treatment 2006, 31:187-194.
11. Mattick R.P., Breen C., Kimber J., Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews 2009, 3:CD002209.
12. Metcalf C.A., Malotte C.K., Douglas J.M., Paul S.M., Dillon B.A., Cross H., Brookes L.C., Deaugustine N., Lindsey C.A., Byers R.H., Peterman T.A. Efficacy of a booster counseling session 6 months after HIV testing and counseling: A randomized, controlled trial. Sexually Transmitted Diseases 2005, 32:123-129. RESPECT-2 Study Group.
13. Metsch L.R., Feaster D.J., Gooden L., Matheson T., Mandler R.N., Haynes L., Tross S., Kyle T., Gallup D., Kosinski A.S., Douaihy A., Schackman B.R., Das M., Lindblad R., Erickson S., Korthuis P.T., Martino S., Sorensen J.L., Szapocznik J., Walensky R., Branson B., Colfax G.N. Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: Results of a randomized trial. American Journal of Public Health 2012, 102:1160-1167. [Epub 2012 Apr 19.2012].
14. Metzger D.S., Koblin B., Turner C., Navaline H., Valenti F., Holte S., Gross M., Sheon A., Miller H., Cooley P., Seage G.R. Randomized controlled trial of audio computer-assisted self-interviewing: Utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. American Journal of Epidemiology 2000, 152:99-106.
15. Murrill C.S., Prevots D.R., Miller M.S., Linley L.A., Royalty J.E., Gwinn M. Incidence of HIV among injection drug users entering drug treatment programs in four US cities. Journal of Urban Health 2001, 78:152-161. Seroincidence Study Group.
16. National HIV/AIDS Strategy for the United States (2010). The White House Office of National AIDS Policy. July, 2010. Accessed at on August 6, 2012. http://www.whitehouse.gov/sites/default/files/uploads/NHAS.pdf.
17. National Survey of Substance Abuse Treatment Services (N-SSATS). (2010). 2010 State Profile - United States. Rockville, MD: Substance Abuse and Mental Health Services Administration. Office of Applied Studies. accessed August 3, 2012. http://wwwdasis.samhsa.gov/10nssats/nssats2010web.pdf.
18. Perlis T.E., Des Jarlais D.C., Friedman S.R., Arasteh K., Turner C.F. Audio-computerized self-interviewing versus face-to-face interviewing for research data collection at drug abuse treatment programs. Addiction 2004, 99:885-896.
19. Polinsky M.L., Hser Y.I., Anglin M.D., Maglione M.A. Drug-user treatment programs in a large metropolitan area. Substance Use and Misuse 1998, 33:1735-1761.
20. Pollack H.A., D'Aunno T. HIV testing and counseling in the nation's outpatient substance abuse treatment system, 1995-2005. Journal of Substance Abuse Treatment 2010, 38:307-316.
21. Pollack H.A., D'Aunno T., Lamar B. Outpatient substance abuse treatment and HIV prevention: An update. Journal of Substance Abuse Treatment 2006 Jan, 30:39-47.
22. Shah N.G., Celentano D.D., Vlahov D., Stambolis V., Johnson L., Nelson K.E., Strathdee S.A. Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus. AIDS 2000, 14:2035-2043.
23. Sorensen J.L., Masson C.L., Perlman D.C. HIV/Hepatitis prevention in drug abuse treatment programs: Guidance from research. Science and Practice Perspectives 2002, 1:4-11.
24. Strauss S.M., Falkin G.P., Vassilev Z., Des Jarlais D.C., Astone J. A nationwide survey of hepatitis C services provided by drug treatment programs. Journal of Substance Abuse Treatment 2002, 22:55-62.
25. Turner C.F., Ku L., Rogers S.M., Lindberg L.D., Pleck J.H., Sonenstein F.L. Adolescent sexual behavior, drug use, and violence: Increased reporting with computer survey technology. Science 1998, 280:867-873.
26. Wood E., Tyndall M.W., Spittal P.M., Li K., Hogg R.S., Montaner J.S.G., O'Shaughnessy M.V., Schechter M.T. Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. Journal of AIDS 2002, 16:941-943.